CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 360

Industry reads hand-picked by our editors

May 27, 2015

In-Pharmatechnologist
Novartis to assess... 'sugar needles?'
Reuters
Researchers oppose unvalidated gene panel tests for cancer links
Reuters
CA scientists test Ecstasy as anxiety-reducer for gravely ill

May 26, 2015

Reuters
U.S. bird flu virus could be under control within 4 months
Reuters
Fight over hot new cholesterol drugs could be won in miligrams
Bloomberg
Covered CA first to cap monthly specialty drug co-pays

May 22, 2015

Reuters
Keytruda also wins an EU recommendation
Reuters
EU regulator confirms rec to suspend drugs over flawed studies
In-Pharmatechnologist
Is opiate production about to get way too easy?

May 21, 2015

Reuters
DEA announces four state crackdown on illegal 'pill mills'
FiercePharma
Price watchdogs raise eyebrows at uniQure gene therapy
FierceBiotech
Sarepta surges after kicking off rolling submission for DMD drug

May 20, 2015

Reuters
Lpath to cut jobs as eye drug fails in mid-stage trial
In-Pharmatechnologist
EMA: Show clinical justification for combination drugs
Bloomberg
Money flows again to gene therapy drugs investors once shunned

May 19, 2015

Reuters
FDA considers expanding tests for drug residues in milk
Reuters
Science leaders to tackle ethics of gene-editing technology
FiercePharma
Actavis talks to DOJ about resolving Warner Chilcott marketing probe

May 18, 2015

Reuters
Hot flash alternative meds are hit or miss
Reuters
Germany's Merkel urges tighter WHO management after Ebola 'catastrophe'
Bloomberg
Endo's consolation for missing out on Salix: Par Pharma
Pharma Times
Boehringer snaps up Pharmaxis liver disease drug

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Trendline
The state of drug pricing in 2024 Supported by GoodRx
Trendline
The latest developments in oncology research Supported by EVERSANA
Webinar - on demand
Biomanufacturing: Scale-up vs Scale-out Economics Custom content for Cytiva

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
4 major trends shaping today’s oncology market Webinar - on demand • Provided by Advisory Board
Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.